The World Health Organisation (WHO) said it's updating its guidelines on COVID-19 treatment to reflect the trial results of a common steroid in critical COVID-19 cases.
The preliminary results showed that dexamethasone reduced death rates by about one third for critically ill patients.
"This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support," WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.
The agency said it will "coordinate a meta-analysis to increase our overall understanding of this intervention" and update the guidelines to "reflect how and when the drug should be used in COVID-19".
The drug has been used since the 1960s to reduce inflammation in diseases such as arthritis.
Family of alleged Bondi gunman unaware of 'radical mindset', say Indian police
Israeli forces kill Palestinian teen in West Bank, health ministry says
Trump sues BBC for defamation, seeks up to $10 billion in damages
FBI foils 'terror plot' targeting Los Angeles
Hong Kong court finds tycoon Jimmy Lai guilty in landmark security trial
